Paper · 41733136
High prevalence of maturity-onset diabetes of the young in the Czech Republic: A 25-year nationwide registry-based study.
Dusatkova P and 8 others. Diabet Med, 2026. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. High prevalence of maturity-onset diabetes of the young in the Czech Republic: A 25-year nationwide registry-based study. Papers, record 41733136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41733136
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High prevalence of maturity-onset diabetes of the young in the Czech Republic: A 25-year nationwide registry-based study.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Humans | |
| Czech Republic | |
| Prevalence | |
| Registries | |
| Female | |
| Male | |
| Hepatocyte Nuclear Factor 1-alpha | |
| Hepatocyte Nuclear Factor 4 | |
| Adolescent | |
| Adult | |
| Young Adult | |
| Child | |
| Germinal Center Kinases | |
| Child, Preschool | |
| Protein Serine-Threonine Kinases |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Ministerstvo Zdravotnictví Ceské Republiky | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25,557,782 | Uncovering the genetic history of the present-day Greenlandic population. | Am J Hum Genet | 2015 | https://conductscience.org/library/papers/25557782 | PubMed |
| 2 | 36,537,518 | ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. | Pediatr Diabetes | 2022 | https://conductscience.org/library/papers/36537518 | PubMed |
| 3 | 36,599,947 | Monogenic diabetes mellitus hidden in autoantibody-negative diabetes mellitus. | Nat Rev Endocrinol | 2023 | https://conductscience.org/library/papers/36599947 | PubMed |
| 4 | 32,086,287 | Systematic Genetic Study of Youth With Diabetes in a Single Country Reveals the Prevalence of Diabetes Subtypes, Novel Candidate Genes, and Response to Precision Therapy. | Diabetes | 2020 | https://conductscience.org/library/papers/32086287 | PubMed |
| 5 | 28,323,911 | Monogenic Diabetes Accounts for 6.3% of Cases Referred to 15 Italian Pediatric Diabetes Centers During 2007 to 2012. | J Clin Endocrinol Metab | 2017 | https://conductscience.org/library/papers/28323911 | PubMed |
| 6 | 33,560,999 | Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors' Expert Forum. | Diabetes Care | 2020 | https://conductscience.org/library/papers/33560999 | PubMed |
| 7 | 34,789,499 | Syndromic Monogenic Diabetes Genes Should Be Tested in Patients With a Clinical Suspicion of Maturity-Onset Diabetes of the Young. | Diabetes | 2022 | https://conductscience.org/library/papers/34789499 | PubMed |
| 8 | 24,550,216 | The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort. | Diabetes Care | 2014 | https://conductscience.org/library/papers/24550216 | PubMed |
| 9 | 40,853,921 | Genetic and Clinical Characteristics of Monogenic Diabetes in Japan: A Nationwide Study by the Japan Diabetes Society. | J Clin Endocrinol Metab | 2026 | https://conductscience.org/library/papers/40853921 | PubMed |
| 10 | 24,092,492 | Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. | Diabetologia | 2014 | https://conductscience.org/library/papers/24092492 | PubMed |
1 to 10 of 36
See all 36 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
None in this release.
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCK | 2,645 | PubTator's text mining | https://conductscience.org/library/genes/2645 | NCBI Gene |
| HNF1A | 6,927 | PubTator's text mining | https://conductscience.org/library/genes/6927 | NCBI Gene |
| HNF4A | 3,172 | PubTator's text mining | https://conductscience.org/library/genes/3172 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41733136
GET https://conductscience.org/api/papers/v1/41733136/references?page=2